BIOE Bio Essence Corporation

USD 0.26 0.00 0
Icon

Bio Essence Corporation (BIOE) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - Specialty & Generic | OTC
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.26

0.00 (0.00)%

USD 9.88M

N/A

N/A

N/A

Icon

BIOE

Bio Essence Corporation (USD)
COMMON STOCK | OTC
USD 0.26
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 9.88M

N/A

USD 0.26

Bio Essence Corporation (BIOE) Stock Forecast

N/A

Based on the Bio Essence Corporation stock forecast from 0 analysts, the average analyst target price for Bio Essence Corporation is not available over the next 12 months. Bio Essence Corporation’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Bio Essence Corporation is Bearish, which is based on 2 positive signals and 5 negative signals. At the last closing, Bio Essence Corporation’s stock price was USD 0.26. Bio Essence Corporation’s stock price has changed by +0.00% over the past week, +0.00% over the past month and -74.26% over the last year.

No recent analyst target price found for Bio Essence Corporation
No recent average analyst rating found for Bio Essence Corporation

Company Overview Bio Essence Corporation

Bio Essence Corporation operates as an herbal health, diet, and nutrition company in the United States and internationally. It targets healthcare practitioners with herbal products in the form of granules, capsules, pills, and tablets; offers special formulation, original equipme...Read More

8 Studebaker Drive, Irvine, CA, United States, 92618

11

December

USD

USA

Adjusted Closing Price for Bio Essence Corporation (BIOE)

Loading...

Unadjusted Closing Price for Bio Essence Corporation (BIOE)

Loading...

Share Trading Volume for Bio Essence Corporation Shares

Loading...

Compare Performance of Bio Essence Corporation Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BIOE

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Bio Essence Corporation (Sector: Drug Manufacturers - Specialty & Generic )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
MKGAF
MERCK Kommanditgesellschaft au.. 0.00 (0.00%) USD76.84B 24.08 14.94

ETFs Containing BIOE

Symbol Name BIOE's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Bio Essence Corporation (BIOE) Stock

Stock Target Advisor's fundamental analysis for Bio Essence Corporation's stock is Bearish.

Unfortunately we do not have enough data on BIOE's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on BIOE's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on BIOE's stock to indicate if its overvalued.

The last closing price of BIOE's stock was USD 0.26.

The most recent market capitalization for BIOE is USD 9.88M.

Unfortunately we do not have enough analyst data on BIOE's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Bio Essence Corporation's stock.

As per our most recent records Bio Essence Corporation has 11 Employees.

Bio Essence Corporation's registered address is 8 Studebaker Drive, Irvine, CA, United States, 92618. You can get more information about it from Bio Essence Corporation's website at https://www.bioessencecorp.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...